| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$187,515 ) |
| | 2025 | 2025 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL146810 | YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | 000 | 4 | NIH | 11/20/2024 | $573,667 |
| | 2025 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL170051 | From variants to mechanisms for cardiac arrhythmias | 000 | 2 | NIH | 4/22/2025 | -$761,182 |
|
| Issue Date FY: 2024 ( Subtotal = $2,304,418 ) |
| | 2024 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL170051 | From variants to mechanisms for cardiac arrhythmias | 000 | 2 | NIH | 6/18/2024 | $761,182 |
| | 2024 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL146810 | YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | 000 | 3 | NIH | 11/17/2023 | $573,667 |
| | 2024 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL158816 | Molecular and morphometric imaging of coagulation and inflammation in pulmonary embolism pathogenesis | 000 | 1 | NIH | 9/13/2024 | $728,651 |
| | 2024 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R21AR081535 | Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus | 000 | 2 | NIH | 3/8/2024 | $176,220 |
| | 2024 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R21AR081535 | Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus | 001 | 2 | NIH | 5/21/2024 | $13,706 |
| | 2024 | 2024 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL146810 | YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | 001 | 3 | NIH | 6/24/2024 | $50,992 |
| | 2024 | 2022 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 000 | 5 | NIH | 1/8/2024 | $0 |
| | 2024 | 2021 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 000 | 9 | NIH | 10/19/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,555,284 ) |
| | 2023 | 2023 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL170051 | From variants to mechanisms for cardiac arrhythmias | 000 | 1 | NIH | 7/26/2023 | $825,573 |
| | 2023 | 2023 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL146810 | YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | 001 | 2 | NIH | 3/10/2023 | $64,630 |
| | 2023 | 2023 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R21AR079085 | Mechanistic insights into polyphosphate-mediated osteoinduction. | 000 | 2 | NIH | 5/18/2023 | $193,050 |
| | 2023 | 2023 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R21AR081535 | Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus | 000 | 1 | NIH | 2/15/2023 | $234,960 |
| | 2023 | 2023 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL146810 | YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | 000 | 2 | NIH | 11/16/2022 | $581,677 |
| | 2023 | 2021 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 003 | 3 | NIH | 5/4/2023 | -$437,500 |
| | 2023 | 2020 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 006 | 2 | NIH | 6/7/2023 | $69,092 |
| | 2023 | 2020 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 005 | 2 | NIH | 5/15/2023 | -$69,092 |
| | 2023 | 2020 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 002 | 2 | NIH | 5/4/2023 | -$69,092 |
| | 2023 | 2020 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 001 | 2 | NIH | 12/13/2022 | $161,986 |
|
| Issue Date FY: 2022 ( Subtotal = $1,059,637 ) |
| | 2022 | 2022 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 001 | 4 | NIH | 7/19/2022 | -$393,750 |
| | 2022 | 2022 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 000 | 4 | NIH | 2/18/2022 | $393,750 |
| | 2022 | 2022 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 000 | 5 | NIH | 7/18/2022 | $167,400 |
| | 2022 | 2022 | MASONIC MEDICAL RESEARCH LAB | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R21AR079085 | Mechanistic insights into polyphosphate-mediated osteoinduction. | 000 | 1 | NIH | 6/3/2022 | $251,270 |
| | 2022 | 2022 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL146810 | YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses | 000 | 1 | NIH | 12/27/2021 | $640,967 |
|
| Issue Date FY: 2021 ( Subtotal = $1,462,447 ) |
| | 2021 | 2021 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 004 | 4 | NIH | 6/5/2021 | $167,400 |
| | 2021 | 2021 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 002 | 9 | NIH | 5/18/2021 | $75,379 |
| | 2021 | 2021 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 001 | 9 | NIH | 12/30/2020 | $678,418 |
| | 2021 | 2021 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 000 | 3 | NIH | 3/25/2021 | $437,500 |
| | 2021 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 000 | 8 | NIH | 10/26/2020 | $0 |
| | 2021 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 003 | 3 | NIH | 5/4/2021 | -$99,502 |
| | 2021 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 006 | 3 | NIH | 7/14/2021 | $103,750 |
| | 2021 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 001 | 3 | NIH | 2/9/2021 | $99,502 |
| | 2021 | 2019 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL122238 | Targeted inhibition of fibrosis for the prevention of heart failure | 000 | 5 | NIH | 7/30/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,402,243 ) |
| | 2020 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 003 | 3 | NIH | 8/5/2020 | $167,400 |
| | 2020 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 001 | 3 | NIH | 6/2/2020 | $167,400 |
| | 2020 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | K01HL140187 | Defining the functional variation underlying atrial fibrillation risk | 002 | 3 | NIH | 8/3/2020 | -$167,400 |
| | 2020 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 001 | 8 | NIH | 1/28/2020 | $39,868 |
| | 2020 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 000 | 8 | NIH | 12/12/2019 | $757,475 |
| | 2020 | 2020 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL147044 | Mechanisms of Lipotoxic Arrhythmias | 001 | 2 | NIH | 3/9/2020 | $437,500 |
| | 2020 | 2017 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R56HL138454 | VGLL4 and IRF2BP2 regulation of cardiomyocyte survival and hypertrophy | 000 | 2 | NIH | 3/12/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $2,324,443 ) (Continued on the next page) |
| | 2019 | 2019 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 003 | 7 | NIH | 2/13/2019 | $499,090 |
| | 2019 | 2019 | MASONIC MEDICAL RESEARCH LABORATORY | 2150 BLEECKER ST | UTICA | NY | 13501-1738 | ONEIDA | USA | R01HL122238 | Targeted inhibition of fibrosis for the prevention of heart failure | 000 | 5 | NIH | 3/28/2019 | $797,039 |
|
